Zuo, M. 2023. Comparison of Efficacy and Safety of Imatinib and Dasatinib in the Treatment of Chronic-phase Chronic Myeloid Leukemia. Highlights in Science, Engineering and Technology. 74, (Dec. 2023), 1807–1816. DOI:https://doi.org/10.54097/yf8hhr56.